| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL19A1 COL1A2 | 3.06e-21 | 46 | 38 | 11 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL19A1 COL1A2 | 3.70e-14 | 188 | 38 | 11 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | SHANK1 COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 DLG2 COL5A3 COL6A5 COL8A2 COL11A2 COL19A1 AHNAK COL1A2 | 3.99e-10 | 891 | 38 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 1.92e-04 | 11 | 38 | 2 | GO:0098919 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 2.71e-04 | 13 | 38 | 2 | GO:0098879 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 1.03e-03 | 25 | 38 | 2 | GO:0016702 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 1.11e-03 | 26 | 38 | 2 | GO:0016701 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 1.69e-03 | 32 | 38 | 2 | GO:0099186 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4-phosphate binding | 2.13e-03 | 36 | 38 | 2 | GO:0070273 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 2.89e-03 | 42 | 38 | 2 | GO:0098918 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 3.47e-03 | 1356 | 38 | 8 | GO:0060090 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL8A2 COL11A2 MMP2 COL19A1 COL1A2 | 5.09e-11 | 377 | 38 | 11 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL8A2 COL11A2 MMP2 COL19A1 COL1A2 | 5.23e-11 | 378 | 38 | 11 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL8A2 COL11A2 MMP2 COL19A1 COL1A2 | 5.38e-11 | 379 | 38 | 11 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 1.25e-06 | 12 | 38 | 3 | GO:0038063 | |
| GeneOntologyBiologicalProcess | response to acid chemical | 3.51e-06 | 228 | 38 | 6 | GO:0001101 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 4.62e-06 | 18 | 38 | 3 | GO:0038065 | |
| GeneOntologyBiologicalProcess | cellular response to amino acid stimulus | 1.11e-05 | 161 | 38 | 5 | GO:0071230 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.14e-05 | 76 | 38 | 4 | GO:0030199 | |
| GeneOntologyBiologicalProcess | cellular response to acid chemical | 1.75e-05 | 177 | 38 | 5 | GO:0071229 | |
| GeneOntologyBiologicalProcess | response to amino acid | 3.31e-05 | 202 | 38 | 5 | GO:0043200 | |
| GeneOntologyBiologicalProcess | maintenance of postsynaptic density structure | 1.18e-04 | 9 | 38 | 2 | GO:0099562 | |
| GeneOntologyBiologicalProcess | glomerular basement membrane development | 1.47e-04 | 10 | 38 | 2 | GO:0032836 | |
| GeneOntologyBiologicalProcess | maintenance of postsynaptic specialization structure | 4.42e-04 | 17 | 38 | 2 | GO:0098880 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-1 | 5.13e-04 | 85 | 38 | 3 | GO:0071347 | |
| GeneOntologyCellularComponent | collagen trimer | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL19A1 COL1A2 | 3.01e-18 | 88 | 37 | 11 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | 3.40e-15 | 21 | 37 | 7 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 IL16 COL11A2 MMP2 COL19A1 COL1A2 | 3.16e-12 | 530 | 37 | 13 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 IL16 COL11A2 MMP2 COL19A1 COL1A2 | 4.53e-11 | 656 | 37 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 IL16 COL11A2 MMP2 COL19A1 COL1A2 | 4.71e-11 | 658 | 37 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.24e-10 | 6 | 37 | 4 | GO:0005587 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL8A2 COL11A2 COL19A1 COL1A2 | 2.12e-10 | 332 | 37 | 10 | GO:0005788 |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 5.78e-10 | 8 | 37 | 4 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 5.78e-10 | 8 | 37 | 4 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 5.78e-10 | 8 | 37 | 4 | GO:0098645 | |
| GeneOntologyCellularComponent | basement membrane | 7.00e-08 | 122 | 37 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.11e-06 | 12 | 37 | 3 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.11e-06 | 12 | 37 | 3 | GO:0098643 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL4A2 COL4A3 COL4A4 JPH2 COL4A6 COL5A3 COL11A2 MMP2 AHNAK COL1A2 | 2.86e-05 | 1187 | 37 | 10 | GO:0099081 |
| HumanPheno | Abnormality of refraction | SOX4 COL4A3 COL4A4 COL4A6 HGD CACNA1F COL18A1 COL8A2 COL11A2 RAI1 COL1A2 | 1.96e-06 | 709 | 17 | 11 | HP:0000539 |
| HumanPheno | Lenticonus | 3.65e-06 | 10 | 17 | 3 | HP:0001142 | |
| HumanPheno | Myopia | SOX4 COL4A3 COL4A4 COL4A6 CACNA1F COL18A1 COL11A2 RAI1 COL1A2 | 3.66e-06 | 447 | 17 | 9 | HP:0000545 |
| HumanPheno | Abnormality of lens shape | 2.44e-05 | 18 | 17 | 3 | HP:0011526 | |
| HumanPheno | Retinal detachment | 3.03e-05 | 118 | 17 | 5 | HP:0000541 | |
| HumanPheno | Abnormal cornea morphology | COL4A4 COL4A6 HGD CACNA1F COL18A1 COL8A2 MMP2 RAI1 DNMT3B COL1A2 | 3.06e-05 | 744 | 17 | 10 | HP:0000481 |
| HumanPheno | Glomerular basement membrane lamellation | 3.14e-05 | 3 | 17 | 2 | HP:0030034 | |
| HumanPheno | Anterior lenticonus | 3.14e-05 | 3 | 17 | 2 | HP:0011501 | |
| HumanPheno | Thin glomerular basement membrane | 3.14e-05 | 3 | 17 | 2 | HP:0012577 | |
| HumanPheno | Tendon rupture | 1.04e-04 | 5 | 17 | 2 | HP:0100550 | |
| HumanPheno | Ocular hypertension | 2.24e-04 | 37 | 17 | 3 | HP:0007906 | |
| HumanPheno | Asymmetry of intraocular pressure | 2.42e-04 | 38 | 17 | 3 | HP:0012633 | |
| HumanPheno | Abnormal intraocular pressure | 2.62e-04 | 39 | 17 | 3 | HP:0012632 | |
| HumanPheno | Abnormal anterior eye segment morphology | COL4A3 COL4A4 COL4A6 HGD CACNA1F COL18A1 COL8A2 COL11A2 MMP2 RAI1 DNMT3B COL1A2 | 3.76e-04 | 1450 | 17 | 12 | HP:0004328 |
| MousePheno | expanded mesangial matrix | 4.43e-06 | 46 | 34 | 4 | MP:0011353 | |
| MousePheno | abnormal articular cartilage morphology | 4.70e-06 | 14 | 34 | 3 | MP:0006433 | |
| MousePheno | abnormal mesangial matrix morphology | 6.72e-06 | 51 | 34 | 4 | MP:0011338 | |
| MousePheno | abnormal synovial joint morphology | 1.15e-05 | 124 | 34 | 5 | MP:0030804 | |
| MousePheno | abnormal joint morphology | 3.92e-05 | 397 | 34 | 7 | MP:0002932 | |
| MousePheno | abnormal glomerular mesangium morphology | 4.68e-05 | 83 | 34 | 4 | MP:0011339 | |
| MousePheno | sensorineural hearing loss | 9.65e-05 | 37 | 34 | 3 | MP:0004740 | |
| MousePheno | abnormal extracellular matrix morphology | 9.70e-05 | 100 | 34 | 4 | MP:0013258 | |
| MousePheno | increased large unstained cell number | 1.05e-04 | 38 | 34 | 3 | MP:0012362 | |
| MousePheno | sensorineural hearing impairment | 1.05e-04 | 38 | 34 | 3 | MP:0006329 | |
| MousePheno | podocyte foot process effacement | 1.05e-04 | 38 | 34 | 3 | MP:0008140 | |
| MousePheno | abnormal hyaline cartilage morphology | 1.86e-04 | 46 | 34 | 3 | MP:0006429 | |
| MousePheno | abnormal heart left ventricle morphology | 2.34e-04 | 369 | 34 | 6 | MP:0003921 | |
| MousePheno | abnormal large unstained cell number | 2.83e-04 | 53 | 34 | 3 | MP:0012360 | |
| MousePheno | abnormal renal filtration | 3.00e-04 | 54 | 34 | 3 | MP:0013285 | |
| MousePheno | abnormal podocyte foot process morphology | 3.16e-04 | 55 | 34 | 3 | MP:0008059 | |
| MousePheno | short snout | 3.17e-04 | 136 | 34 | 4 | MP:0000445 | |
| MousePheno | small snout | 3.94e-04 | 144 | 34 | 4 | MP:0030190 | |
| MousePheno | abnormal heart ventricle morphology | 5.02e-04 | 793 | 34 | 8 | MP:0005294 | |
| MousePheno | impaired lipolysis | 5.13e-04 | 14 | 34 | 2 | MP:0008033 | |
| MousePheno | broad snout | 5.91e-04 | 15 | 34 | 2 | MP:0030189 | |
| MousePheno | abnormal nasal bone morphology | 6.17e-04 | 69 | 34 | 3 | MP:0000102 | |
| MousePheno | abnormal podocyte morphology | 6.44e-04 | 70 | 34 | 3 | MP:0005326 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 6.44e-04 | 70 | 34 | 3 | MP:0011497 | |
| MousePheno | abnormal blood circulation | 7.66e-04 | 845 | 34 | 8 | MP:0002128 | |
| Domain | Collagen | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL19A1 COL1A2 | 9.66e-18 | 85 | 38 | 11 | PF01391 |
| Domain | Collagen | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL19A1 COL1A2 | 9.66e-18 | 85 | 38 | 11 | IPR008160 |
| Domain | C4 | 2.18e-10 | 6 | 38 | 4 | SM00111 | |
| Domain | - | 2.18e-10 | 6 | 38 | 4 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 2.18e-10 | 6 | 38 | 4 | IPR001442 | |
| Domain | NC1_IV | 2.18e-10 | 6 | 38 | 4 | PS51403 | |
| Domain | C4 | 2.18e-10 | 6 | 38 | 4 | PF01413 | |
| Domain | TSPN | 1.25e-07 | 23 | 38 | 4 | SM00210 | |
| Domain | NC1_FIB | 1.27e-06 | 11 | 38 | 3 | PS51461 | |
| Domain | Fib_collagen_C | 1.27e-06 | 11 | 38 | 3 | IPR000885 | |
| Domain | Fib_collagen_C | 1.27e-06 | 11 | 38 | 3 | PD002078 | |
| Domain | COLFI | 1.27e-06 | 11 | 38 | 3 | SM00038 | |
| Domain | COLFI | 1.27e-06 | 11 | 38 | 3 | PF01410 | |
| Domain | CTDL_fold | 2.43e-06 | 107 | 38 | 5 | IPR016187 | |
| Domain | Laminin_G | 5.71e-06 | 58 | 38 | 4 | IPR001791 | |
| Domain | LamG | 9.71e-05 | 44 | 38 | 3 | SM00282 | |
| Domain | PDZ | 1.88e-04 | 141 | 38 | 4 | PF00595 | |
| Domain | PDZ | 2.27e-04 | 148 | 38 | 4 | SM00228 | |
| Domain | - | 2.39e-04 | 150 | 38 | 4 | 2.30.42.10 | |
| Domain | PDZ | 2.45e-04 | 151 | 38 | 4 | PS50106 | |
| Domain | PDZ | 2.51e-04 | 152 | 38 | 4 | IPR001478 | |
| Domain | - | 9.45e-04 | 95 | 38 | 3 | 2.60.120.200 | |
| Domain | ConA-like_dom | 9.93e-04 | 219 | 38 | 4 | IPR013320 | |
| Domain | Laminin_G_2 | 2.99e-03 | 40 | 38 | 2 | PF02210 | |
| Domain | SH3_2 | 1.32e-02 | 86 | 38 | 2 | IPR011511 | |
| Domain | SH3_2 | 1.32e-02 | 86 | 38 | 2 | PF07653 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 MMP2 COL19A1 COL1A2 | 1.64e-21 | 53 | 35 | 12 | MM14566 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL19A1 COL1A2 | 1.15e-20 | 41 | 35 | 11 | MM15538 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 MMP2 COL19A1 COL1A2 | 1.98e-20 | 64 | 35 | 12 | M26953 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL19A1 COL1A2 | 2.79e-20 | 44 | 35 | 11 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL19A1 COL1A2 | 1.48e-18 | 61 | 35 | 11 | MM14637 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL19A1 COL1A2 | 4.50e-18 | 67 | 35 | 11 | M26999 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL19A1 COL1A2 | 1.98e-17 | 76 | 35 | 11 | MM14573 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL1A2 | 2.08e-17 | 50 | 35 | 10 | MM14796 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 MMP2 COL19A1 COL1A2 | 3.09e-17 | 114 | 35 | 12 | MM14571 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL19A1 COL1A2 | 1.41e-16 | 90 | 35 | 11 | M631 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL1A2 | 1.79e-16 | 61 | 35 | 10 | M27103 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 MMP2 COL19A1 COL1A2 | 3.91e-16 | 140 | 35 | 12 | M587 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL1A2 | 1.49e-13 | 76 | 35 | 9 | MM14867 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL1A2 | 4.24e-13 | 85 | 35 | 9 | M16441 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 MMP2 COL19A1 COL1A2 | 6.28e-13 | 258 | 35 | 12 | MM14572 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 9.89e-13 | 32 | 35 | 7 | MM14924 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 MMP2 COL19A1 COL1A2 | 3.74e-12 | 300 | 35 | 12 | M610 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 9.56e-11 | 59 | 35 | 7 | M27218 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 2.07e-10 | 15 | 35 | 5 | M27161 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 5.86e-10 | 18 | 35 | 5 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 5.86e-10 | 18 | 35 | 5 | MM14882 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.95e-10 | 76 | 35 | 7 | M27219 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.06e-09 | 20 | 35 | 5 | MM15061 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.30e-09 | 46 | 35 | 6 | M198 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 6.61e-09 | 10 | 35 | 4 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 6.61e-09 | 10 | 35 | 4 | MM1560 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 9.55e-09 | 30 | 35 | 5 | M27216 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.04e-08 | 11 | 35 | 4 | M15422 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.22e-08 | 66 | 35 | 6 | M18 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.55e-08 | 12 | 35 | 4 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 2.24e-08 | 13 | 35 | 4 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 2.24e-08 | 13 | 35 | 4 | M12950 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 2.45e-08 | 74 | 35 | 6 | M160 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.13e-08 | 14 | 35 | 4 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 3.13e-08 | 14 | 35 | 4 | M6487 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.31e-08 | 38 | 35 | 5 | MM14969 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.26e-08 | 15 | 35 | 4 | MM14922 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 5.28e-08 | 84 | 35 | 6 | M7098 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 5.58e-08 | 42 | 35 | 5 | M7169 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.50e-07 | 20 | 35 | 4 | M15394 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.67e-07 | 57 | 35 | 5 | MM14713 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.73e-07 | 23 | 35 | 4 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.73e-07 | 23 | 35 | 4 | MM1427 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.92e-07 | 58 | 35 | 5 | M2049 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 4.44e-07 | 63 | 35 | 5 | M11187 | |
| Pathway | KEGG_FOCAL_ADHESION | 4.84e-07 | 199 | 35 | 7 | M7253 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 3.67e-06 | 43 | 35 | 4 | M53 | |
| Pathway | WP_FOCAL_ADHESION | 5.93e-06 | 187 | 35 | 6 | MM15913 | |
| Pathway | WP_FOCAL_ADHESION | 8.47e-06 | 199 | 35 | 6 | M39402 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.32e-05 | 19 | 35 | 3 | MM15512 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.93e-05 | 261 | 35 | 6 | MM15676 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 4.40e-05 | 28 | 35 | 3 | MM15957 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 4.49e-05 | 161 | 35 | 5 | M39770 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 5.44e-05 | 30 | 35 | 3 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.44e-05 | 30 | 35 | 3 | MM15517 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 6.28e-05 | 418 | 35 | 7 | MM15587 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 8.84e-05 | 302 | 35 | 6 | M39719 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 8.99e-05 | 96 | 35 | 4 | M39834 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.35e-04 | 326 | 35 | 6 | MM15917 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.40e-04 | 41 | 35 | 3 | M27778 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 1.62e-04 | 43 | 35 | 3 | M39565 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.67e-04 | 339 | 35 | 6 | M39736 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.11e-04 | 47 | 35 | 3 | MM14925 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.81e-04 | 532 | 35 | 7 | M27870 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 6.02e-04 | 67 | 35 | 3 | MM15345 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 9.74e-04 | 79 | 35 | 3 | M27643 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 9.97e-04 | 19 | 35 | 2 | M27221 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 1.16e-03 | 84 | 35 | 3 | M3228 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.33e-03 | 502 | 35 | 6 | MM14537 | |
| Pathway | WP_CANCER_PATHWAYS | 1.40e-03 | 507 | 35 | 6 | M48302 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 2.02e-03 | 27 | 35 | 2 | M27217 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.65e-03 | 575 | 35 | 6 | M29853 | |
| Pathway | WP_IL17_SIGNALING | 2.83e-03 | 32 | 35 | 2 | M39560 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 2.83e-03 | 32 | 35 | 2 | MM15326 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 3.01e-03 | 33 | 35 | 2 | M39875 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 3.01e-03 | 33 | 35 | 2 | M26976 | |
| Pathway | PID_FRA_PATHWAY | 3.78e-03 | 37 | 35 | 2 | M65 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 3.98e-03 | 38 | 35 | 2 | MM14611 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 4.30e-03 | 439 | 35 | 5 | M42563 | |
| Pathway | PID_HNF3A_PATHWAY | 5.31e-03 | 44 | 35 | 2 | M285 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 5.54e-03 | 45 | 35 | 2 | M39864 | |
| Pathway | WP_CCL18_SIGNALING | 7.35e-03 | 52 | 35 | 2 | M42542 | |
| Pathway | WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER | 7.90e-03 | 54 | 35 | 2 | M42568 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 8.27e-03 | 325 | 35 | 4 | M12868 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 8.48e-03 | 56 | 35 | 2 | M27616 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL4A2 COL4A3 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL1A2 | 2.93e-14 | 135 | 39 | 9 | 28675934 |
| Pubmed | 1.71e-13 | 9 | 39 | 5 | 9878537 | ||
| Pubmed | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL11A2 COL1A2 | 3.13e-13 | 175 | 39 | 9 | 28071719 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 5.93e-13 | 62 | 39 | 7 | 28344315 | |
| Pubmed | 6.39e-12 | 153 | 39 | 8 | 25037231 | ||
| Pubmed | 1.29e-11 | 167 | 39 | 8 | 22159717 | ||
| Pubmed | 1.56e-11 | 19 | 39 | 5 | 15689378 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 2.02e-11 | 6 | 39 | 4 | 9506531 | |
| Pubmed | 2.02e-11 | 6 | 39 | 4 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 2.02e-11 | 6 | 39 | 4 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 2.02e-11 | 6 | 39 | 4 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 2.02e-11 | 6 | 39 | 4 | 6389236 | |
| Pubmed | 2.02e-11 | 6 | 39 | 4 | 12225806 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 2.02e-11 | 6 | 39 | 4 | 10534397 | |
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 2.02e-11 | 6 | 39 | 4 | 9673377 | |
| Pubmed | 2.02e-11 | 6 | 39 | 4 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 2.02e-11 | 6 | 39 | 4 | 19275937 | |
| Pubmed | 2.02e-11 | 6 | 39 | 4 | 6988303 | ||
| Pubmed | 4.71e-11 | 7 | 39 | 4 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 4.71e-11 | 7 | 39 | 4 | 8006028 | |
| Pubmed | 4.71e-11 | 7 | 39 | 4 | 10416788 | ||
| Pubmed | 4.71e-11 | 7 | 39 | 4 | 1724753 | ||
| Pubmed | 9.42e-11 | 8 | 39 | 4 | 3997552 | ||
| Pubmed | 9.42e-11 | 8 | 39 | 4 | 29422532 | ||
| Pubmed | 9.42e-11 | 8 | 39 | 4 | 1377218 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 9.42e-11 | 8 | 39 | 4 | 11867580 | |
| Pubmed | 9.42e-11 | 8 | 39 | 4 | 10382266 | ||
| Pubmed | 1.69e-10 | 9 | 39 | 4 | 10880400 | ||
| Pubmed | 1.69e-10 | 9 | 39 | 4 | 12101409 | ||
| Pubmed | 2.82e-10 | 10 | 39 | 4 | 9415455 | ||
| Pubmed | 2.82e-10 | 10 | 39 | 4 | 9136074 | ||
| Pubmed | 4.43e-10 | 11 | 39 | 4 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 4.43e-10 | 11 | 39 | 4 | 7500359 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 6.64e-10 | 12 | 39 | 4 | 12180907 | |
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 6.64e-10 | 12 | 39 | 4 | 15837576 | |
| Pubmed | 6.64e-10 | 12 | 39 | 4 | 16024816 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 3089234 | ||
| Pubmed | 1.34e-09 | 14 | 39 | 4 | 12878203 | ||
| Pubmed | 1.49e-09 | 186 | 39 | 7 | 20673868 | ||
| Pubmed | 1.49e-09 | 186 | 39 | 7 | 20452482 | ||
| Pubmed | 2.43e-09 | 16 | 39 | 4 | 15878328 | ||
| Pubmed | 3.46e-09 | 210 | 39 | 7 | 16537572 | ||
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 5.21e-09 | 4 | 39 | 3 | 7827955 | |
| Pubmed | 1.30e-08 | 5 | 39 | 3 | 9409248 | ||
| Pubmed | 1.98e-08 | 26 | 39 | 4 | 24742657 | ||
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 7495302 | ||
| Pubmed | 2.60e-08 | 6 | 39 | 3 | 10722718 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 2.88e-08 | 79 | 39 | 5 | 18757743 | |
| Pubmed | 4.15e-08 | 31 | 39 | 4 | 22925884 | ||
| Pubmed | 4.55e-08 | 7 | 39 | 3 | 10639489 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 4.55e-08 | 7 | 39 | 3 | 10716744 | |
| Pubmed | 4.55e-08 | 7 | 39 | 3 | 7521231 | ||
| Pubmed | 4.69e-08 | 87 | 39 | 5 | 20548288 | ||
| Pubmed | 7.27e-08 | 8 | 39 | 3 | 11683410 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 7.27e-08 | 8 | 39 | 3 | 10970885 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 9.74e-08 | 736 | 39 | 9 | 29676528 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 9.95e-08 | 101 | 39 | 5 | 20551380 | |
| Pubmed | 1.09e-07 | 9 | 39 | 3 | 8562707 | ||
| Pubmed | 1.09e-07 | 9 | 39 | 3 | 8995276 | ||
| Pubmed | 1.20e-07 | 40 | 39 | 4 | 27068110 | ||
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 2.14e-07 | 11 | 39 | 3 | 9731539 | |
| Pubmed | 2.85e-07 | 12 | 39 | 3 | 8918877 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 3.70e-07 | 13 | 39 | 3 | 9833687 | |
| Pubmed | 4.70e-07 | 14 | 39 | 3 | 19858219 | ||
| Pubmed | 5.88e-07 | 15 | 39 | 3 | 10625553 | ||
| Pubmed | 5.88e-07 | 15 | 39 | 3 | 9264260 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 5.88e-07 | 15 | 39 | 3 | 10706142 | |
| Pubmed | Biglycan and decorin differentially regulate signaling in the fetal membranes. | 7.23e-07 | 16 | 39 | 3 | 24373743 | |
| Pubmed | 1.05e-06 | 18 | 39 | 3 | 9160753 | ||
| Pubmed | Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family. | 1.23e-06 | 2 | 39 | 2 | 28674241 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 9537506 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 7987396 | ||
| Pubmed | Heterozygous COL4A3/COL4A4 mutations: the hidden part of the iceberg? | 1.23e-06 | 2 | 39 | 2 | 35090027 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 29742505 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 38214412 | ||
| Pubmed | Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases. | 1.23e-06 | 2 | 39 | 2 | 17216251 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 35369551 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 25307543 | ||
| Pubmed | Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome. | 1.23e-06 | 2 | 39 | 2 | 27281700 | |
| Pubmed | [From Alport syndrome to benign familial hematuria: clinical and genetic aspect]. | 1.23e-06 | 2 | 39 | 2 | 16895672 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 30443360 | ||
| Pubmed | COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. | 1.23e-06 | 2 | 39 | 2 | 24052634 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 19357112 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 12768082 | ||
| Pubmed | Endostatin binds to the catalytic domain of matrix metalloproteinase-2. | 1.23e-06 | 2 | 39 | 2 | 12023034 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 25229338 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 17942953 | ||
| Pubmed | Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus. | 1.23e-06 | 2 | 39 | 2 | 20029656 | |
| Pubmed | Persistent familial hematuria in children and the locus for thin basement membrane nephropathy. | 1.23e-06 | 2 | 39 | 2 | 16235097 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 25381091 | ||
| Pubmed | Collagen type IV (alpha3-alpha4) nephropathy: from isolated haematuria to renal failure. | 1.23e-06 | 2 | 39 | 2 | 15280517 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 15880327 | ||
| Pubmed | Presumed COL4A3/COL4A4 Missense/Synonymous Variants Induce Aberrant Splicing. | 1.23e-06 | 2 | 39 | 2 | 35386907 | |
| Pubmed | COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. | 1.23e-06 | 2 | 39 | 2 | 12028435 | |
| Pubmed | Polymorphism analysis of COL4A3 and COL4A4 genes in Greek patients with keratoconus. | 1.23e-06 | 2 | 39 | 2 | 25083577 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 20847057 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 18661361 | ||
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 32232700 | ||
| Pubmed | 1.71e-06 | 21 | 39 | 3 | 23325811 | ||
| Pubmed | 1.71e-06 | 21 | 39 | 3 | 27856617 | ||
| Interaction | MMP9 interactions | 3.78e-11 | 67 | 38 | 7 | int:MMP9 | |
| Interaction | DCN interactions | 1.66e-08 | 43 | 38 | 5 | int:DCN | |
| Interaction | CD93 interactions | 2.10e-08 | 45 | 38 | 5 | int:CD93 | |
| Interaction | HABP2 interactions | 3.23e-08 | 18 | 38 | 4 | int:HABP2 | |
| Interaction | OSM interactions | 5.09e-08 | 20 | 38 | 4 | int:OSM | |
| Interaction | TGFBI interactions | 1.32e-07 | 25 | 38 | 4 | int:TGFBI | |
| Interaction | COL5A1 interactions | 1.38e-07 | 65 | 38 | 5 | int:COL5A1 | |
| Interaction | FBLN2 interactions | 1.49e-07 | 66 | 38 | 5 | int:FBLN2 | |
| Interaction | MMP2 interactions | 5.99e-07 | 87 | 38 | 5 | int:MMP2 | |
| Interaction | COL8A2 interactions | 1.14e-06 | 42 | 38 | 4 | int:COL8A2 | |
| Interaction | LAIR2 interactions | 2.14e-06 | 49 | 38 | 4 | int:LAIR2 | |
| Interaction | SERPINE2 interactions | 3.68e-06 | 56 | 38 | 4 | int:SERPINE2 | |
| Interaction | COLGALT2 interactions | 7.56e-06 | 67 | 38 | 4 | int:COLGALT2 | |
| Interaction | COL4A2 interactions | 1.19e-05 | 75 | 38 | 4 | int:COL4A2 | |
| Interaction | COL1A2 interactions | 1.39e-05 | 78 | 38 | 4 | int:COL1A2 | |
| Interaction | COL4A6 interactions | 1.56e-05 | 26 | 38 | 3 | int:COL4A6 | |
| Interaction | RNF123 interactions | 1.71e-05 | 824 | 38 | 9 | int:RNF123 | |
| Interaction | COL5A2 interactions | 2.18e-05 | 29 | 38 | 3 | int:COL5A2 | |
| Interaction | ANTXR2 interactions | 2.18e-05 | 29 | 38 | 3 | int:ANTXR2 | |
| Interaction | PLOD3 interactions | 2.30e-05 | 183 | 38 | 5 | int:PLOD3 | |
| Interaction | BGN interactions | 2.42e-05 | 30 | 38 | 3 | int:BGN | |
| Interaction | MATN2 interactions | 5.97e-05 | 113 | 38 | 4 | int:MATN2 | |
| Interaction | C1QTNF1 interactions | 9.47e-05 | 47 | 38 | 3 | int:C1QTNF1 | |
| Interaction | COL4A1 interactions | 1.01e-04 | 48 | 38 | 3 | int:COL4A1 | |
| Interaction | SAA1 interactions | 1.44e-04 | 54 | 38 | 3 | int:SAA1 | |
| Interaction | FN1 interactions | 1.51e-04 | 848 | 38 | 8 | int:FN1 | |
| Interaction | COL5A3 interactions | 1.54e-04 | 10 | 38 | 2 | int:COL5A3 | |
| Interaction | PLOD1 interactions | 2.09e-04 | 292 | 38 | 5 | int:PLOD1 | |
| Interaction | POSTN interactions | 2.67e-04 | 13 | 38 | 2 | int:POSTN | |
| Interaction | CLPSL1 interactions | 2.67e-04 | 13 | 38 | 2 | int:CLPSL1 | |
| Interaction | POLR3F interactions | 3.80e-04 | 75 | 38 | 3 | int:POLR3F | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q36 | 2.40e-03 | 85 | 39 | 2 | chr2q36 | |
| Cytoband | Xp11.23 | 2.99e-03 | 95 | 39 | 2 | Xp11.23 | |
| GeneFamily | Collagens | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL19A1 COL1A2 | 1.00e-22 | 46 | 27 | 11 | 490 |
| GeneFamily | PDZ domain containing | 7.25e-05 | 152 | 27 | 4 | 1220 | |
| Coexpression | NABA_COLLAGENS | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL19A1 COL1A2 | 6.70e-23 | 43 | 38 | 11 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL19A1 COL1A2 | 8.92e-23 | 44 | 38 | 11 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL19A1 COL1A2 | 1.06e-13 | 270 | 38 | 11 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 COL11A2 COL19A1 COL1A2 | 1.30e-13 | 275 | 38 | 11 | M5884 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 2.27e-11 | 40 | 38 | 6 | M5887 | |
| Coexpression | NABA_MATRISOME | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 IL16 COL11A2 MMP2 COL19A1 COL1A2 | 8.26e-10 | 1008 | 38 | 13 | MM17056 |
| Coexpression | NABA_MATRISOME | COL4A2 COL4A3 COL4A4 COL4A6 COL18A1 COL5A3 COL6A5 COL8A2 IL16 COL11A2 MMP2 COL19A1 COL1A2 | 1.02e-09 | 1026 | 38 | 13 | M5889 |
| Coexpression | MANALO_HYPOXIA_UP | 4.77e-07 | 205 | 38 | 6 | M259 | |
| Coexpression | LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE | 7.59e-07 | 49 | 38 | 4 | M2899 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 4.88e-06 | 23 | 38 | 3 | M48001 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 4.89e-06 | 681 | 38 | 8 | M39175 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 7.11e-06 | 505 | 38 | 7 | M39167 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.01e-05 | 200 | 38 | 5 | M5930 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 1.49e-05 | 33 | 38 | 3 | M9167 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 4.46e-05 | 136 | 38 | 4 | M2005 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 5.88e-05 | 146 | 38 | 4 | MM856 | |
| Coexpression | STARK_HYPPOCAMPUS_22Q11_DELETION_UP | 6.26e-05 | 53 | 38 | 3 | MM582 | |
| Coexpression | STARK_HYPPOCAMPUS_22Q11_DELETION_UP | 6.63e-05 | 54 | 38 | 3 | M12050 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 9.02e-05 | 163 | 38 | 4 | M12112 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_DN | 1.00e-04 | 62 | 38 | 3 | M16774 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED | 1.34e-04 | 12 | 38 | 2 | M47983 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.70e-04 | 74 | 38 | 3 | M13547 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.76e-04 | 194 | 38 | 4 | M39122 | |
| Coexpression | DARWICHE_PAPILLOMA_PROGRESSION_RISK | 1.91e-04 | 77 | 38 | 3 | M1147 | |
| Coexpression | GSE17721_12H_VS_24H_PAM3CSK4_BMDC_DN | 1.98e-04 | 200 | 38 | 4 | M4118 | |
| Coexpression | DESCARTES_FETAL_CEREBRUM_VASCULAR_ENDOTHELIAL_CELLS | 1.99e-04 | 595 | 38 | 6 | M40167 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 2.06e-04 | 79 | 38 | 3 | M18400 | |
| Coexpression | BAKER_HEMATOPOIESIS_STAT3_TARGETS | 2.12e-04 | 15 | 38 | 2 | M1163 | |
| Coexpression | BAKER_HEMATOPOIESIS_STAT3_TARGETS | 2.12e-04 | 15 | 38 | 2 | MM1109 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 2.14e-04 | 80 | 38 | 3 | MM1285 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN | 2.22e-04 | 384 | 38 | 5 | M12527 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 2.22e-04 | 81 | 38 | 3 | M39253 | |
| Coexpression | MCLACHLAN_DENTAL_CARIES_DN | 2.30e-04 | 82 | 38 | 3 | M1278 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_2B | 2.35e-04 | 389 | 38 | 5 | M4995 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 2.38e-04 | 83 | 38 | 3 | M2448 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_1_CELL | 2.41e-04 | 391 | 38 | 5 | M41659 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 2.48e-04 | 212 | 38 | 4 | M39221 | |
| Coexpression | LEIN_CEREBELLUM_MARKERS | 2.56e-04 | 85 | 38 | 3 | MM720 | |
| Coexpression | LEIN_CEREBELLUM_MARKERS | 2.56e-04 | 85 | 38 | 3 | M1723 | |
| Coexpression | KANG_AR_TARGETS_UP | 2.75e-04 | 17 | 38 | 2 | MM1297 | |
| Coexpression | KANG_AR_TARGETS_UP | 2.75e-04 | 17 | 38 | 2 | M2223 | |
| Coexpression | WANG_CISPLATIN_RESPONSE_AND_XPC_DN | 2.80e-04 | 219 | 38 | 4 | M14385 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 3.09e-04 | 18 | 38 | 2 | M47984 | |
| Coexpression | DARWICHE_PAPILLOMA_PROGRESSION_RISK | 3.23e-04 | 92 | 38 | 3 | MM503 | |
| Coexpression | HUMMERICH_MALIGNANT_SKIN_TUMOR_UP | 3.45e-04 | 19 | 38 | 2 | M1126 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 3.96e-04 | 240 | 38 | 4 | M39236 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 4.09e-04 | 681 | 38 | 6 | M5314 | |
| Coexpression | BENPORATH_ES_CORE_NINE_CORRELATED | 4.13e-04 | 100 | 38 | 3 | M14079 | |
| Coexpression | WINTER_HYPOXIA_METAGENE | 4.15e-04 | 243 | 38 | 4 | M14072 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_VS_70PLS_0DY_UP | 4.64e-04 | 22 | 38 | 2 | M40867 | |
| Coexpression | KANNAN_TP53_TARGETS_DN | 4.64e-04 | 22 | 38 | 2 | M11403 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 4.84e-04 | 703 | 38 | 6 | MM1055 | |
| Coexpression | HUMMERICH_MALIGNANT_SKIN_TUMOR_UP | 5.08e-04 | 23 | 38 | 2 | MM492 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | 5.53e-04 | 721 | 38 | 6 | M1999 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 5.60e-04 | 111 | 38 | 3 | M45685 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED | 6.51e-04 | 26 | 38 | 2 | M47981 | |
| Coexpression | ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN | 6.51e-04 | 26 | 38 | 2 | M8224 | |
| Coexpression | WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP | 6.51e-04 | 26 | 38 | 2 | M8924 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 6.70e-04 | 276 | 38 | 4 | M3063 | |
| Coexpression | NGUYEN_NOTCH1_TARGETS_UP | 7.02e-04 | 27 | 38 | 2 | M15592 | |
| Coexpression | WESTON_VEGFA_TARGETS_12HR | 7.02e-04 | 27 | 38 | 2 | M1545 | |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 | 7.91e-04 | 125 | 38 | 3 | M1969 | |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 | 9.26e-04 | 132 | 38 | 3 | MM841 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.01e-09 | 121 | 39 | 6 | 5035e071033cb76a7fc0128716755b14821e8f05 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Inmt_(Inmt)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.01e-09 | 121 | 39 | 6 | c96115bd33455296378a257583b49442d00b39ca | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-08 | 180 | 39 | 6 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-08 | 180 | 39 | 6 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-08 | 188 | 39 | 6 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-08 | 191 | 39 | 6 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-08 | 200 | 39 | 6 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 3.66e-07 | 169 | 39 | 5 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.14e-07 | 181 | 39 | 5 | 634a4f4e5942473e60d08d0b0936407b04bc6b7c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes-Pericyte-Peri_L1-6_MUSTN1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.14e-07 | 181 | 39 | 5 | c2938cf1f5d4875be07a56a1f36c94f8eab37d99 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.14e-07 | 181 | 39 | 5 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.28e-07 | 182 | 39 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-07 | 184 | 39 | 5 | c9d7ec17cc5b7ba1b1e721ca392746e8f4a3d41f | |
| ToppCell | Pericytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 5.57e-07 | 184 | 39 | 5 | 3d2d55d0f22874be21665ab37da710482f77fc36 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.88e-07 | 186 | 39 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.04e-07 | 187 | 39 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.04e-07 | 187 | 39 | 5 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.04e-07 | 187 | 39 | 5 | 6f47a80e612b320f571210483e62ff5db2a8ea43 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 6.20e-07 | 188 | 39 | 5 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.20e-07 | 188 | 39 | 5 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.20e-07 | 188 | 39 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | Pericytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 6.20e-07 | 188 | 39 | 5 | 14c1c88a944c66f2eaac1ce7526815dcce1f5147 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-07 | 189 | 39 | 5 | bba28f57a0708515fdd5acd9592dbbe4a4f57116 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-07 | 189 | 39 | 5 | cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.36e-07 | 189 | 39 | 5 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-07 | 189 | 39 | 5 | 87323e86a5b5d159920a07e6bd7ef5e3438cd085 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-07 | 190 | 39 | 5 | 8cb950effc449ae59a915132ecc079be54d1acfe | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-07 | 190 | 39 | 5 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-07 | 190 | 39 | 5 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 6.53e-07 | 190 | 39 | 5 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-07 | 190 | 39 | 5 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-07 | 190 | 39 | 5 | 5dfbd064ab1f8a0b18b5975c47f8e79697f3db15 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-07 | 190 | 39 | 5 | 17a73a658fb30a4322b31e38db7b240023738f29 | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 6.70e-07 | 191 | 39 | 5 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-07 | 192 | 39 | 5 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-07 | 192 | 39 | 5 | b35f0e422070ba9c7c1d9ff3eace4edc10286cde | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 6.87e-07 | 192 | 39 | 5 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.87e-07 | 192 | 39 | 5 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-07 | 192 | 39 | 5 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 7.05e-07 | 193 | 39 | 5 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.05e-07 | 193 | 39 | 5 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.23e-07 | 194 | 39 | 5 | e2db75f4de114631b8bda4e188f84446545538b7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Mesenchymal|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 7.23e-07 | 194 | 39 | 5 | 638b9fdce64ed00243b5303800ec66207d5fd640 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 7.23e-07 | 194 | 39 | 5 | e9868c22934b6c0ac35e3e8270ec0b671bc6582a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.23e-07 | 194 | 39 | 5 | a7731378f44ca1a229311686caf5740c742d21ba | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.42e-07 | 195 | 39 | 5 | 78978d85273e5463a7f43e4c121e647fa6aba42b | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 7.42e-07 | 195 | 39 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.61e-07 | 196 | 39 | 5 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.61e-07 | 196 | 39 | 5 | 8c25fa61c117a60ddd4cbd2f95ae5b66f986a1ec | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.61e-07 | 196 | 39 | 5 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.61e-07 | 196 | 39 | 5 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.80e-07 | 197 | 39 | 5 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.80e-07 | 197 | 39 | 5 | 01249bd485a3734de87ae6ed9c749597f39c6335 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.80e-07 | 197 | 39 | 5 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.80e-07 | 197 | 39 | 5 | 69fde2d27881f8408216e231c71cfdbd96f28d45 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.80e-07 | 197 | 39 | 5 | 4a04da876a1482604452ae53c124ae68eda0bd5e | |
| ToppCell | ASK440-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.80e-07 | 197 | 39 | 5 | 782449c522c9e16e72bf999a73090688a3aefe06 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 7.80e-07 | 197 | 39 | 5 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.00e-07 | 198 | 39 | 5 | d83707b69fb64721ac3cff90ba58cdd999d6b386 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-07 | 198 | 39 | 5 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.00e-07 | 198 | 39 | 5 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 8.00e-07 | 198 | 39 | 5 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.00e-07 | 198 | 39 | 5 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 8.20e-07 | 199 | 39 | 5 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | cellseq-Mesenchymal-Myocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.20e-07 | 199 | 39 | 5 | 20e62a7029fa0d214244cdf2a481fc5d78290438 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.20e-07 | 199 | 39 | 5 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.20e-07 | 199 | 39 | 5 | a272c54baf8de59c0f259e6498d144a0de8d8924 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 8.20e-07 | 199 | 39 | 5 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 8.20e-07 | 199 | 39 | 5 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.20e-07 | 199 | 39 | 5 | 6139687a3a5025cb98da4dba0183f95fcae3dc61 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.20e-07 | 199 | 39 | 5 | 2e7f517c0444b4f29ff11c26ab32e9cc0f7e99ef | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Smooth_Muscle_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 8.20e-07 | 199 | 39 | 5 | 31c781a1787e5140fb3f611823cbab4d13d02dfa | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-07 | 200 | 39 | 5 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 8.41e-07 | 200 | 39 | 5 | 7642a14855589b0b3f68dbdc9e4d3fc7291854f7 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial|10w / Sample Type, Dataset, Time_group, and Cell type. | 8.41e-07 | 200 | 39 | 5 | ff0b2675c68e9fc1fa16b3276431f199f3642eac | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-07 | 200 | 39 | 5 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-07 | 200 | 39 | 5 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.41e-07 | 200 | 39 | 5 | c5d818203bef80ff97c2e0158cf61970673dd258 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Smooth_Muscle_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 8.41e-07 | 200 | 39 | 5 | 55ac281901309e30978da1f7489386e54489721e | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.41e-07 | 200 | 39 | 5 | 444c72334df421375ae6fc69b0adfd4950d49a43 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.41e-07 | 200 | 39 | 5 | 5826c17da67bdaba3a828792279004218d8260c8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuroepithelial-Proteoglycan-expressing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 8.41e-07 | 200 | 39 | 5 | 07d2133c85e0a4eb8bef653ee15ecd0f1b2bbd44 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-07 | 200 | 39 | 5 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-07 | 200 | 39 | 5 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.91e-06 | 129 | 39 | 4 | 856255fbfc7f95642000cfd7704141b2388f7c5c | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Acta2Rgs5.Fos_(Mural.Acta2Rgs5.Fos)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.23e-06 | 137 | 39 | 4 | 5ca712230a888403769547c2e03760131abaa4cf | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Acta2Rgs5.Fos_(Mural.Acta2Rgs5.Fos)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.23e-06 | 137 | 39 | 4 | 2282caba7a59d7c0d7a3de8b04a94a24fa01d10c | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-06 | 138 | 39 | 4 | e2659949944bdf39b23c7275e380a7a937e2726c | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-06 | 138 | 39 | 4 | d5342383c5e52b92c39d7afe76560501be3ea5cd | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.91e-06 | 150 | 39 | 4 | 4bdcdce40f54580c7a4e1416b468e657ba8874fc | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.89e-06 | 154 | 39 | 4 | 65dbb60f636562eeba3dafadae9c0c7db2b27476 | |
| ToppCell | AT1-AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-05 | 155 | 39 | 4 | 010e45ef4b505bf419ea41e4d1619521d1c78319 | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.09e-05 | 158 | 39 | 4 | 944c5fe625f965dd6153dbcbf5577f99ad343983 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-05 | 158 | 39 | 4 | 32c95c1bc9e50fccd6d06e828f29258fc5e568cb | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.15e-05 | 160 | 39 | 4 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-05 | 163 | 39 | 4 | 4dfd408aa700e307478ee35f6b902f68719d8d9e | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-MAIT|ICU-SEP / Disease, Lineage and Cell Type | 1.27e-05 | 164 | 39 | 4 | db863a44fc0dad5518c47fdbf64ea21d6f36f089 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.30e-05 | 165 | 39 | 4 | 570483b43ccb5831feec9337b4664814431d40b1 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT1|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.30e-05 | 165 | 39 | 4 | b9b6b7b8cd65ba6948a5dd8b715cc7092e0be637 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.30e-05 | 165 | 39 | 4 | 2026a9a07f4d314cc05c167e491312b373468e46 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.02e-04 | 50 | 20 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.02e-04 | 50 | 20 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | ECM and collagens. | 6.96e-04 | 225 | 20 | 4 | MODULE_47 | |
| Drug | Tranilast sodium | COL4A3 COL4A6 COL18A1 COL8A2 TNFAIP1 COL11A2 MMP2 COL19A1 PTGS1 COL1A2 | 3.04e-15 | 115 | 38 | 10 | CID000005527 |
| Drug | pirfenidone | COL4A3 COL4A6 COL18A1 COL8A2 TNFAIP1 COL11A2 MMP2 COL19A1 PTGS1 COL1A2 | 1.97e-14 | 138 | 38 | 10 | CID000040632 |
| Drug | BAPN | 2.70e-13 | 71 | 38 | 8 | CID000001647 | |
| Drug | halofuginone lactate | 1.20e-12 | 85 | 38 | 8 | CID000062891 | |
| Drug | d-indobufen | 1.90e-12 | 50 | 38 | 7 | CID000044562 | |
| Drug | 4-hydroxyproline | 2.11e-12 | 91 | 38 | 8 | CID000000825 | |
| Drug | ticlopidine | 5.81e-12 | 103 | 38 | 8 | CID000005472 | |
| Drug | hydroxylysine | 9.23e-12 | 109 | 38 | 8 | CID000001029 | |
| Drug | AC1LAKND | 9.25e-12 | 62 | 38 | 7 | CID000470146 | |
| Drug | GK-101 | 2.68e-11 | 36 | 38 | 6 | CID000161853 | |
| Drug | silibinin | COL4A3 COL4A6 COL18A1 COL8A2 TNFAIP1 COL11A2 MMP2 COL19A1 PTGS1 COL1A2 | 2.80e-11 | 285 | 38 | 10 | CID000005213 |
| Drug | AC1NMZ1B | 3.67e-11 | 75 | 38 | 7 | CID005034185 | |
| Drug | DL-penicillamine | 6.60e-11 | 139 | 38 | 8 | CID000004727 | |
| Drug | PCR 4099 | 6.60e-11 | 139 | 38 | 8 | CID000002806 | |
| Drug | Madecassol | 1.27e-10 | 46 | 38 | 6 | CID000108062 | |
| Drug | ridogrel | 2.75e-10 | 52 | 38 | 6 | CID005362391 | |
| Drug | NSC49633 | 3.10e-10 | 53 | 38 | 6 | CID000023340 | |
| Drug | AC1L1DD6 | 4.99e-10 | 179 | 38 | 8 | CID000002299 | |
| Drug | AC1L9732 | 7.27e-10 | 114 | 38 | 7 | CID000439300 | |
| Drug | malotilate | 1.89e-09 | 71 | 38 | 6 | CID000004006 | |
| Drug | DMSe | 2.04e-09 | 132 | 38 | 7 | CID000020796 | |
| Drug | strontium ranelate | 3.11e-09 | 77 | 38 | 6 | CID006918182 | |
| Drug | AC1Q6PCP | 3.62e-09 | 230 | 38 | 8 | CID000005267 | |
| Drug | losartan | COL4A3 COL4A6 COL18A1 COL8A2 COL11A2 MMP2 COL19A1 PTGS1 COL1A2 | 9.29e-09 | 378 | 38 | 9 | CID000003961 |
| Drug | hyaluronan | 1.03e-08 | 263 | 38 | 8 | CID000024759 | |
| Drug | khellin | 1.24e-08 | 171 | 38 | 7 | CID000003828 | |
| Drug | aspirin | COL4A3 COL4A6 COL18A1 COL8A2 TNFAIP1 COL11A2 MMP2 COL19A1 PTGS1 COL1A2 | 2.00e-08 | 563 | 38 | 10 | CID000002244 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 2.47e-08 | 189 | 38 | 7 | CID000001413 | |
| Drug | foscarnet | 2.56e-08 | 190 | 38 | 7 | CID000003414 | |
| Drug | AC1L1C2F | 2.70e-08 | 110 | 38 | 6 | CID000001711 | |
| Drug | PPACK | 3.17e-08 | 113 | 38 | 6 | CID003036757 | |
| Drug | Deptropine citrate [2169-75-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 3.52e-08 | 199 | 38 | 7 | 5543_UP | |
| Drug | LS-63783 | COL4A3 JPH2 COL4A6 COL18A1 COL8A2 TNFAIP1 COL11A2 MMP2 COL19A1 PTGS1 COL1A2 | 5.00e-08 | 804 | 38 | 11 | CID000000231 |
| Drug | AC1L18QD | 5.33e-08 | 325 | 38 | 8 | CID000000213 | |
| Drug | Selara | 5.80e-08 | 125 | 38 | 6 | CID000150310 | |
| Drug | candesartan cilexetil | 1.40e-07 | 145 | 38 | 6 | CID000002540 | |
| Drug | prostacyclin sodium salt | 1.67e-07 | 250 | 38 | 7 | CID000000159 | |
| Drug | colchine | 1.88e-07 | 383 | 38 | 8 | CID000002833 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 2.70e-07 | 162 | 38 | 6 | CID000072363 | |
| Drug | chondroitin sulfate | 3.33e-07 | 413 | 38 | 8 | CID000024766 | |
| Drug | Y-27632 | 5.75e-07 | 444 | 38 | 8 | CID000005711 | |
| Drug | AC1L1KMJ | 9.70e-07 | 476 | 38 | 8 | CID000030956 | |
| Drug | meloxicam | 2.28e-06 | 56 | 38 | 4 | CID000004051 | |
| Drug | NOC 18 | 2.37e-06 | 16 | 38 | 3 | ctd:C093285 | |
| Drug | AC1L916B | 2.87e-06 | 17 | 38 | 3 | CID000436250 | |
| Drug | nickel | 2.92e-06 | 552 | 38 | 8 | CID000000934 | |
| Drug | n-butoxyethanol | 4.26e-06 | 581 | 38 | 8 | ctd:C017096 | |
| Drug | baicalin | 4.69e-06 | 67 | 38 | 4 | CID000064982 | |
| Drug | L-3,4-dehydroproline | 6.61e-06 | 73 | 38 | 4 | CID000094284 | |
| Drug | alitretinoin | 9.82e-06 | 301 | 38 | 6 | ctd:C103303 | |
| Drug | LMWH | 1.12e-05 | 663 | 38 | 8 | CID000000772 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 1.25e-05 | 314 | 38 | 6 | CID000447989 | |
| Drug | Orlistat; Up 200; 10uM; PC3; HT_HG-U133A | 1.62e-05 | 192 | 38 | 5 | 6388_UP | |
| Drug | Sertaconazole nitrate [99592-39-9]; Up 200; 8uM; HL60; HT_HG-U133A | 1.97e-05 | 200 | 38 | 5 | 6128_UP | |
| Drug | Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; PC3; HT_HG-U133A | 1.97e-05 | 200 | 38 | 5 | 5735_UP | |
| Drug | isodesmosine | 2.26e-05 | 33 | 38 | 3 | CID000013811 | |
| Drug | Mifepristone | 3.15e-05 | 553 | 38 | 7 | ctd:D015735 | |
| Drug | diethyl phosphate | 4.56e-05 | 119 | 38 | 4 | CID000000654 | |
| Drug | N-methylmesoporphyrin | 4.71e-05 | 42 | 38 | 3 | CID000444708 | |
| Drug | pyrachlostrobin | 4.74e-05 | 811 | 38 | 8 | ctd:C513428 | |
| Drug | aminoguanidine | 4.87e-05 | 121 | 38 | 4 | CID000002146 | |
| Drug | dexketoprofen trometamol | 5.67e-05 | 7 | 38 | 2 | CID000177976 | |
| Drug | 2,3-pentanedione | 6.25e-05 | 129 | 38 | 4 | ctd:C013186 | |
| Drug | NS-398 | 7.41e-05 | 264 | 38 | 5 | CID000004553 | |
| Drug | NSC27366 | 7.55e-05 | 8 | 38 | 2 | CID000231329 | |
| Drug | Sc 40827 | 7.55e-05 | 8 | 38 | 2 | CID000127918 | |
| Drug | gemcitabine | 8.24e-05 | 270 | 38 | 5 | ctd:C056507 | |
| Drug | desmosine | 9.49e-05 | 53 | 38 | 3 | CID000025435 | |
| Drug | AC1Q5BBB | 9.69e-05 | 9 | 38 | 2 | CID000160467 | |
| Drug | isocycloheximide | 1.02e-04 | 905 | 38 | 8 | CID000002900 | |
| Drug | 17-isoprogesterone | 1.02e-04 | 1170 | 38 | 9 | CID000004920 | |
| Drug | allylpyrocatechol | 1.21e-04 | 10 | 38 | 2 | ctd:C523074 | |
| Drug | magnolol | 1.37e-04 | 60 | 38 | 3 | CID000072300 | |
| Drug | Coal Ash | 1.40e-04 | 159 | 38 | 4 | ctd:D060729 | |
| Drug | boric acid | 1.44e-04 | 61 | 38 | 3 | ctd:C032688 | |
| Drug | phorbolol myristate acetate | 1.48e-04 | 11 | 38 | 2 | ctd:C016658 | |
| Drug | CL 42A | 1.48e-04 | 11 | 38 | 2 | CID000127348 | |
| Drug | meticrane | 1.48e-04 | 11 | 38 | 2 | CID000004165 | |
| Drug | candesartan | 1.51e-04 | 162 | 38 | 4 | CID000002541 | |
| Drug | baicalein | 1.51e-04 | 162 | 38 | 4 | CID005281605 | |
| Drug | tanshinone IIA | 1.59e-04 | 63 | 38 | 3 | CID000164676 | |
| Drug | Plant Preparations | 1.69e-04 | 315 | 38 | 5 | ctd:D028321 | |
| Drug | AC1L1HMM | 1.96e-04 | 516 | 38 | 6 | CID000004196 | |
| Drug | 8-oxo-7-hydrodeoxyguanosine | 2.09e-04 | 13 | 38 | 2 | ctd:C067134 | |
| Drug | Chrysin [480-40-0]; Down 200; 15.8uM; HL60; HT_HG-U133A | 2.31e-04 | 181 | 38 | 4 | 3106_DN | |
| Drug | N-(3-oxododecanoyl)-L-homoserine lactone | 2.44e-04 | 14 | 38 | 2 | CID000127864 | |
| Drug | myricetin | 2.56e-04 | 74 | 38 | 3 | CID005281672 | |
| Drug | AC1NSU5S | 2.67e-04 | 75 | 38 | 3 | CID005316299 | |
| Drug | ascorbate-2-phosphate | 2.81e-04 | 15 | 38 | 2 | ctd:C011669 | |
| Drug | Betamethasone-d5 | 2.84e-04 | 1340 | 38 | 9 | CID000003003 | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; PC3; HT_HG-U133A | 2.95e-04 | 193 | 38 | 4 | 3814_DN | |
| Drug | AC1L8OYS | 2.99e-04 | 78 | 38 | 3 | CID000430234 | |
| Drug | Tetrandrine [518-34-3]; Down 200; 6.4uM; HL60; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 2520_DN | |
| Drug | Dapsone [80-08-0]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 5498_UP | |
| Drug | Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; HL60; HG-U133A | 3.01e-04 | 194 | 38 | 4 | 1556_UP | |
| Drug | Skimmianine [83-95-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | 3.01e-04 | 194 | 38 | 4 | 2504_DN | |
| Drug | F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A | 3.07e-04 | 195 | 38 | 4 | 6424_DN | |
| Drug | Esculin Hydrate [531-75-9]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.07e-04 | 195 | 38 | 4 | 6310_DN | |
| Drug | MK-886 | 3.11e-04 | 79 | 38 | 3 | CID003651377 | |
| Drug | Thiorphan [76721-89-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 3.19e-04 | 197 | 38 | 4 | 2752_UP | |
| Disease | collagen disease (implicated_via_orthology) | 4.30e-07 | 12 | 38 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 4.37e-07 | 48 | 38 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | benign familial hematuria (is_implicated_in) | 1.61e-06 | 2 | 38 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | Alport syndrome, recessive type | 1.61e-06 | 2 | 38 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 1.61e-06 | 2 | 38 | 2 | C2931253 | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 1.61e-06 | 2 | 38 | 2 | C4746745 | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 1.61e-06 | 2 | 38 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Thin basement membrane disease | 1.61e-06 | 2 | 38 | 2 | C0403440 | |
| Disease | Benign familial hematuria | 1.61e-06 | 2 | 38 | 2 | cv:C0241908 | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 4.84e-06 | 3 | 38 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | Alport syndrome | 4.84e-06 | 3 | 38 | 2 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 4.84e-06 | 3 | 38 | 2 | cv:CN076135 | |
| Disease | Hematuria, Benign Familial | 9.67e-06 | 4 | 38 | 2 | C0241908 | |
| Disease | glioblastoma (biomarker_via_orthology) | 9.67e-06 | 4 | 38 | 2 | DOID:3068 (biomarker_via_orthology) | |
| Disease | Alport Syndrome | 9.67e-06 | 4 | 38 | 2 | C1567741 | |
| Disease | Alport Syndrome, X-Linked | 1.61e-05 | 5 | 38 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 1.61e-05 | 5 | 38 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 1.61e-05 | 5 | 38 | 2 | C1567744 | |
| Disease | hypertensive nephropathy | 2.41e-05 | 6 | 38 | 2 | C0848548 | |
| Disease | Craniofacial Abnormalities | 4.82e-05 | 156 | 38 | 4 | C0376634 | |
| Disease | intracranial aneurysm (is_implicated_in) | 1.06e-04 | 12 | 38 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | Schizophrenia | 1.18e-04 | 883 | 38 | 7 | C0036341 | |
| Disease | skin melanoma (is_marker_for) | 1.25e-04 | 13 | 38 | 2 | DOID:8923 (is_marker_for) | |
| Disease | waist-hip ratio | 1.40e-04 | 1226 | 38 | 8 | EFO_0004343 | |
| Disease | Autism Spectrum Disorders | 1.81e-04 | 85 | 38 | 3 | C1510586 | |
| Disease | Oral Submucous Fibrosis | 2.44e-04 | 18 | 38 | 2 | C0029172 | |
| Disease | gastric ulcer (biomarker_via_orthology) | 3.34e-04 | 21 | 38 | 2 | DOID:10808 (biomarker_via_orthology) | |
| Disease | Early Pregnancy Loss | 3.76e-04 | 109 | 38 | 3 | C3830362 | |
| Disease | Miscarriage | 3.76e-04 | 109 | 38 | 3 | C4552766 | |
| Disease | Spontaneous abortion | 3.76e-04 | 109 | 38 | 3 | C0000786 | |
| Disease | Abortion, Tubal | 3.76e-04 | 109 | 38 | 3 | C0000822 | |
| Disease | Renal glomerular disease | 4.02e-04 | 23 | 38 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 4.02e-04 | 23 | 38 | 2 | C4521256 | |
| Disease | Liver Cirrhosis, Experimental | 4.31e-04 | 774 | 38 | 6 | C0023893 | |
| Disease | Heart valve disease | 5.15e-04 | 26 | 38 | 2 | C0018824 | |
| Disease | Cerebral Hemorrhage | 5.98e-04 | 28 | 38 | 2 | C2937358 | |
| Disease | Mental Retardation, Psychosocial | 7.65e-04 | 139 | 38 | 3 | C0025363 | |
| Disease | Profound Mental Retardation | 7.65e-04 | 139 | 38 | 3 | C0020796 | |
| Disease | Mental deficiency | 7.65e-04 | 139 | 38 | 3 | C0917816 | |
| Disease | Hereditary hearing loss and deafness | 8.82e-04 | 146 | 38 | 3 | cv:C0236038 | |
| Disease | colorectal adenocarcinoma (is_implicated_in) | 9.35e-04 | 35 | 38 | 2 | DOID:0050861 (is_implicated_in) | |
| Disease | end stage renal disease (is_implicated_in) | 1.28e-03 | 41 | 38 | 2 | DOID:783 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GHKGFLGDSGLPGLK | 771 | Q14031 | |
| LGDSGLPGLKGVHGK | 776 | Q14031 | |
| IGDKGEPGLKGFAGN | 951 | Q01955 | |
| GPHGDLGFKGIKGLL | 1116 | Q01955 | |
| AHGGFKPTGIEGLKP | 336 | Q9UBC3 | |
| SGAKPKLSGFKGGGL | 11 | Q13829 | |
| FAKLGEGKHPEKLGG | 716 | Q2M2I8 | |
| SSGHLDGPGGAILKK | 366 | Q9BYG8 | |
| GFLGLKGPKGREGHA | 801 | P53420 | |
| KGEAGFFGIPGLKGL | 946 | P08572 | |
| GLHFSGPKVEGGVKG | 5616 | Q09666 | |
| KHGKLKFGTFGGLGS | 5816 | Q09666 | |
| KFGTFGGLGSKSKGH | 5821 | Q09666 | |
| GKDGLLAHAFAPGTG | 186 | P08253 | |
| GRAGAHGLSKGPLEK | 1451 | Q7Z5J4 | |
| LTGRHKGDVSFPGGK | 56 | Q8WV74 | |
| PHTGGKPGGFDVKAL | 191 | O60840 | |
| GKAHGHGLCTGPKGQ | 21 | Q9BR39 | |
| KHKGGGRGSGKGELF | 436 | Q8NFM7 | |
| KESLGHGGLPGLGKT | 6 | Q32MK0 | |
| GSLGEAGAPGHKGSK | 971 | P39060 | |
| FSLEGGKGSLHGDKP | 1246 | Q14005 | |
| SGAAAHGPRGLKGEK | 371 | P13942 | |
| LKGHKGEKGEDGFPG | 731 | P13942 | |
| AKGEKGHPGLIGLIG | 1406 | P13942 | |
| GPGFTKALGHGVDLG | 216 | P23219 | |
| TAAHFGGGGGLLHKK | 161 | P78316 | |
| TGDPGKNGDKGHAGL | 501 | P08123 | |
| GGSVPEKGKHGILGA | 71 | F2Z3F1 | |
| KGHKGEPGENGLHGA | 306 | Q14993 | |
| SLGRLGAAKGALHPG | 141 | P17676 | |
| LGKGGKPQFGLGELS | 556 | P25067 | |
| KGLKGFSGPKGGHGD | 1451 | A8TX70 | |
| LFKGPKGLGFSIAGG | 196 | Q15700 | |
| LSLHGGAKKGGDPGG | 161 | P19622 | |
| GLKGDTGPKGEKGHI | 1391 | P25940 | |
| TGPKGEKGHIGLIGL | 1396 | P25940 | |
| EAKQGGFLPGGGSLH | 351 | Q93099 | |
| GFSGGIPSPDKGHRK | 491 | Q9P2Y5 | |
| GAGGGVSKPHAKLIL | 206 | Q06945 | |
| VSKPHAKLILAGGGG | 211 | Q06945 | |
| GVLLHPIFGGGKEKD | 411 | Q6P1X5 | |
| PLLGKGGFGTVFAGH | 36 | Q9P1W9 | |
| PGGLASLGKHRPKGF | 841 | Q9Y566 | |
| GHLGALGVGGSKPAL | 71 | Q9BV97 | |
| LKNGFPGEETHGLGG | 111 | Q8N831 | |
| FQLLPGKLEHGGGLG | 546 | Q96RL6 |